Abstract
Nasopharyngeal carcinoma (NPC) is an epithelial malignant tumor which arises from the mucosa of the nasopharyngeal cavity. NPC usually presents as painless neck lumps. It can also present with nasal, aural and/or opthalmo-neurologic symptoms. Patients in early stage of the disease are often asymptomatic or present with apparently trivial symptoms. Diagnosis is based on histopathological examination of the biopsied tissue obtained through endoscopy of the nasopharynx. Delayed diagnosis remains a problem in NPC. The most common used staging system is the “tumor node metastasis (TNM)” system, jointly developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Cervical Lymph Node
- National Comprehensive Cancer Network
- Nasopharyngeal Carcinoma
- National Comprehensive Cancer Network
- Tumor Node Metastasis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15(10): 1765–1777.
GLOBOCAN2008 v1.2, Cancer Incidence and Mortality Worldwide: IARCCancerBaseNo. 10 International Agency for Research on Cancer, Lyon, France; 2010. http://globocan.iarc.fr.
Pathmanathan R, Prasad U, Chandrika G et al. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146(6):1355–1367.
Prasad U. Cancer of the nasopharynx. A clinical analysis with anatomicopathological orientation. J R Coll Surg Edinb 1972; 17(2): 108–117.
Prasad U. Fossa of Rosenmuller and nasopharyngeal carcinoma. Med J Malaysia 1979; 33(3):222–225.
Prasad U. Nasopharyngeal carcinoma in man. In: Reznik G, Stinson SF, eds. Nasal Tumors in Animals and Man. Boca Raton: CRC Press, 1983:151–185.
Prasad U, Pua KC. Nasopharyngeal carcinoma: a delay in diagnosis. Med J Malaysia 2000; 55(2):230–235.
Skinner DW, Van Hasselt CA, Tsao SY. Nasopharyngeal carcinoma: modes of presentation. Ann Otol Rhinol Laryngol 1991; 100(7):544–551.
Pua KC, Khoo AS, Yap YY et al. Nasopharyngeal Carcinoma Database. Med J Malaysia 2008; 63 Suppl C: 59–62.
Chan JKC, Bray F, McCarron P et al. Nasopharyngeal carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours Vol 9. Lyon: IARC Press, 2005:85–97.
Prasad U. Cells of origin of nasopharyngeal carcinoma: an electron microscopic study. J Laryngol Otol 1974; 88(11): 1087–1094.
Nicholls J, Niedobitek G. Histopathological diagnosis of nasopharyngeal carcinoma–Looking beyond the blue book. In: Busson P, ed. Nasopharyngeal Carcinoma: Keys for Translational Medicine and Biology. Austin/New York: Landes Bioscience/Springer Science+Business Media, 2012:10–22.
Taxy JB, Hidvegi DF, Battifora H. Nasopharyngeal carcinoma: antikeratin immunohistochemistry and electron microscopy. Am J Clin Pathol 1985; 83(3):320–325.
Purposes and Principles of Cancer Staging. In: Edge S, Byrd D, Compton C, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010:3–14.
NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Head and Neck Cancers. 2011. http://www.nccn.org/professionals/physiciangls/pdf/head-and-neck_OnlinePDF.pdf.
Pharynx. In: Edge S, Byrd D, Compton C, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010:41–56.
Pathmanathan R, Prasad U, Sadler R et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333(11):693–698.
Pak MW, To KF, Lo YM et al. Nasopharyngeal carcinoma in situ (NPCIS)—pathologic and clinical perspectives. Head Neck 2002; 24(11):989–995.
King AD, Vlantis AC, Tsang RK et al. Magnetic resonance imaging for the detection of nasopharyngeal carcinoma. AJNR Am J Neuroradiol 2006; 27(6): 1288–1291.
Liao XB, Mao YP, Liu LZ et al. How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? Int J Radiat Oncol Biol Phys 2008; 72(5): 1368–1377.
Ma J, Liu L, Tang L et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res 2007; 13(5): 1445–1452.
Tang L, Li L, Mao Y et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging: prognostic value and staging categories. Cancer 2008; 113(2):347–354.
Tham IW, Hee SW, Yap SP et al. Retropharyngeal nodal metastasis related to higher rate of distant metastasis in patients with NO and N1 nasopharyngeal cancer. Head Neck 2009; 31(4):468–474.
Lin XP, Zhao C, Chen MY et al. Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma. Ai Zheng 2008; 27(9):974–978.
Ng SH, Chan SC, Yen TC et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur JNucl Med Mol Imaging 2009; 36(1): 12–22.
Chua ML, Ong SC, Wee JT et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck 2009; 31(3):346–354.
Liu FY, Lin CY, Chang JT et al. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nuclear Med 2007; 48(10): 1614–1619.
Comoretto M, Balestreri L, Borsatti E et al. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology 2008; 249(l):203–211.
Mao YP, Liang SB, Liu LZ et al. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging. Clin Cancer Res 2008; 14(22):7497–7503.
Chen L, Mao YP, Xie FY et al. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother Oncol 2011.
Prasad U. Problems in the early diagnosis of nasopharyngeal carcinoma: A review of 40 cases. In: Prasad U, ed. Nasopharyngeal Carcinoma. Kuala Lumpur: University of Malaya Press, 2000:233–239.
Prasad UAD, Prathap K et al. Problem of occult primary in nasopharyngeal carcinoma. In: Prasad U, ed. Nasopharyngeal Carcinoma: Current Concepts. Kuala Lumpur: University of Malaya Press, 1983:11–15.
Kaur A, Chew CT, Lim-Tan SK. Fine needle aspiration of 123 head and neck masses—an initial experience. Ann Acad Med Singapore 1993; 22(3):303–306.
Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents: Columbia Univ Press, 1949:196.
Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5(6):649–655.
Lee AW, Foo W, Law SC et al. Recurrent nasopharyngeal carcinoma: the puzzles of long latency. Int J Radiat Oncol Biol Phys 1999; 44(1): 149–156.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Landes Bioscience and Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Khoo, A.SB., Pua, KC. (2013). Diagnosis and Clinical Evaluation of Nasopharyngeal Carcinoma. In: Busson, P. (eds) Nasopharyngeal Carcinoma. Advances in Experimental Medicine and Biology, vol 778. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5947-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5947-7_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5946-0
Online ISBN: 978-1-4614-5947-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)